Markets:

Overview

News

Currencies

International

Treasuries

Outlook Therapeutics, Inc. - Common Stock (NQ:OTLK)

2.440 +0.270 (+12.44%)

Streaming Delayed Price Updated: 3:32 PM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Outlook Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

On Monday, there are stocks with unusual volume. Let's take a look. ↗

November 17, 2025

The trading volume of these stocks is deviating from the norm in today's session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 29, 2025

Via Benzinga

Outlook Therapeutics Stock Nose-Dives 66% In Pre-Market – Here’s Why ↗

August 28, 2025

Via Stocktwits

Top 3 Health Care Stocks That Could Blast Off This Month ↗

January 06, 2025

Via Benzinga

Thursday's session: top gainers and losers ↗

August 28, 2025

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 28, 2025

Via Benzinga

Nasdaq Surges 100 Points; Dollar General Earnings Beat Views ↗

August 28, 2025

Via Benzinga

Topics Earnings

Let's take a look at the stocks that are in motion in today's session. ↗

August 28, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

FDA Rejects Outlook Therapeutics Eye Drug For Second Time ↗

August 28, 2025

Outlook Therapeutics shares fall after the FDA rejects its ONS-5010 wet AMD drug application, citing insufficient efficacy evidence despite prior trial success.

Via Benzinga

The market is filled with gapping stocks in Thursday's session. ↗

August 28, 2025

The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

US Stocks Mixed; Nvidia Posts Upbeat Earnings ↗

August 28, 2025

Via Benzinga

Wondering what's happening in today's pre-market session? ↗

August 28, 2025

Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 27, 2025

Via Benzinga

Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket ↗

August 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 26, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

August 18, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

Outlook Therapeutics Reports Q3 Revenue ↗

August 14, 2025

Via The Motley Fool

Rubrik To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday ↗

June 06, 2025

Via Benzinga

Discover the top movers in Friday's pre-market session. ↗

May 23, 2025

As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 22, 2025

Via Benzinga

Thursday's after hours session: top gainers and losers ↗

May 22, 2025

After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Coinbase To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

February 18, 2025

Via Benzinga

Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug ↗

January 16, 2025

Outlook Therapeutics plans to resubmit ONS-5010 for FDA approval in 2025 following NORSE EIGHT trial results in wet AMD patients.

Via Benzinga

This Kohl's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗

December 02, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 27, 2024

Via Benzinga

Nasdaq Down Over 100 Points; HP Shares Plunge ↗

November 27, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Outlook Therapeutics, Inc. - Common Stock (NQ:OTLK)

Headline News about Outlook Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today